Company: SVV
Filing Date: 2025-05-13
Form Type: S-3
Source: 0001193125-25-118371
Chunk: 58

Company: Savers Value Village, Inc.
Filing Date: 2025-05-13
Form: S-3
Chunk 58
---
 table shows the per share and total underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters’ option to purchase additional shares of common stock. The underwriters S-22

will not receive any underwriting discount for the shares being repurchased by us pursuant to the Concurrent Share Repurchase.

|              |     | Selling Stockholders 
 No Exercise          |     | Full Exercise |
|:-------------|:----|:---------------------|:----|:--------------|
| Per Share(1) |     | $                    |     | $             |
| Total(1)     |     | $                    |     | $             |

| (1) | The underwriters will not receive any discount or commission on the    shares of our 
 common stock we repurchase from the underwriters in the Concurrent Share Repurchase. |

We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $ . The underwriters have agreed to reimburse us for certain expenses incurred by us in connection with this offering. We have also agreed to reimburse the underwriters for certain of their expenses in an amount up to $ . A prospectus in electronic format may be made available on the websites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of shares of common stock to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and selling group members that may make Internet distributions on the same basis as other allocations. We have agreed that, for a period of 75 days after the date of this prospectus supplement, we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences